Canada markets closed

CSPC Pharmaceutical Group Limited (1093.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
6.4800.000 (0.00%)
As of 09:52AM HKT. Market open.
Currency in HKD

Valuation Measures4

Market Cap (intraday) 77.09B
Enterprise Value 63.71B
Trailing P/E 12.12
Forward P/E 11.30
PEG Ratio (5 yr expected) 2.67
Price/Sales (ttm)2.26
Price/Book (mrq)2.15
Enterprise Value/Revenue 2.03
Enterprise Value/EBITDA 7.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3-20.10%
S&P500 52-Week Change 323.57%
52 Week High 38.250
52 Week Low 35.200
50-Day Moving Average 36.205
200-Day Moving Average 36.247

Share Statistics

Avg Vol (3 month) 339.94M
Avg Vol (10 day) 348.9M
Shares Outstanding 511.9B
Implied Shares Outstanding 612.12B
Float 88.26B
% Held by Insiders 129.79%
% Held by Institutions 132.08%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.28
Forward Annual Dividend Yield 44.32%
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 33.92%
5 Year Average Dividend Yield 42.13
Payout Ratio 446.38%
Dividend Date 3N/A
Ex-Dividend Date 4May 31, 2024
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 18.67%
Operating Margin (ttm)23.59%

Management Effectiveness

Return on Assets (ttm)9.96%
Return on Equity (ttm)18.22%

Income Statement

Revenue (ttm)31.45B
Revenue Per Share (ttm)2.65
Quarterly Revenue Growth (yoy)1.90%
Gross Profit (ttm)N/A
EBITDA 7.93B
Net Income Avi to Common (ttm)5.87B
Diluted EPS (ttm)0.530
Quarterly Earnings Growth (yoy)-15.10%

Balance Sheet

Total Cash (mrq)13.76B
Total Cash Per Share (mrq)1.16
Total Debt (mrq)706.9M
Total Debt/Equity (mrq)2.02%
Current Ratio (mrq)2.63
Book Value Per Share (mrq)2.80

Cash Flow Statement

Operating Cash Flow (ttm)4.18B
Levered Free Cash Flow (ttm)1.16B